The ADA limit calculator is an essential tool for ensuring compliance with accessibility standards. By automating calculations, these tools streamline the process of determining measurements and reducing the risk of errors. This, in turn, promotes more accurate designs that are better equipped to meet ADA requirements and foster inclusive environments.
The current method of assessing assay sensitivity relies on a surrogate positive control and therefore, it is not always representative of assay sensitivity in the presence of drug (4,5). Furthermore, assay sensitivity results may be overestimated in the presence of large amounts of drug, which can overwhelm the negative antibody signal at low concentrations, or when drug treatment causes target accumulation and thus, exacerbates assay interference (6, 7).
As a result of these limitations, it is recommended that ADA drug tolerance be assessed using the unspiked samples from cut point evaluations (if applicable) or by testing additional dilutions of the test sample at the highest recommended ADA concentrations for the assay. Additionally, it is also recommended that a series of samples are tested at the lower limit of detection (LPD) and confirmatory assay concentrations to demonstrate selectivity (8, 9).
Beginner’s Guide to Trading with an XLM Limit Order
Regardless of the approach taken for ADA limit determination, selecting the appropriate threshold will ensure that the assay can reliably distinguish between the test sample and the reference sample in the presence of drug. This is an important consideration, as it is the primary factor determining the ability of an ADA method to detect drug in clinical study samples.
